Dar Bioscience Inc (DARE) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Dar Bioscience Inc   (NASDAQ: DARE)


Dar Bioscience Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



DARE Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -
Seq. Revenue Change 23.02 %
Revenue In Millions $0.19
Gross Profit Margin -70.57 %
Gross Profit Margin Total Ranking #
Gross Profit In Millions $-0.13
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Dar Bioscience Inc achieved higher Gross Loss of 0 than a $-0.09 millions reported a quarter before.


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry Dar Bioscience Inc has achieved highest Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to , from total ranking in the previous quarter at 1036.
Learn about Gross Margin
DARE's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
70.49 % 70.49 % 70.49 %
(Dec 31 2025)  




Other Gross Profit Margin Profitability Ratios
DARE's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DARE's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DARE's Competitors
Gross Profit Margin Profit Margin for Dar Bioscience Inc 's Suppliers
Gross Profit Margin Profit Margin for DARE's Customers

You may also want to know
DARE's Annual Growth Rates DARE's Profitability Ratios DARE's Asset Turnover Ratio DARE's Dividend Growth
DARE's Roe DARE's Valuation Ratios DARE's Financial Strength Ratios DARE's Gross Profit Growth
DARE's Roa DARE's Inventory Turnover Ratio DARE's Growth Rates DARE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.